Literature DB >> 29259003

Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange.

Curtis G Jones1, Shannon M Pechauer2, Brian R Curtis3, Daniel W Bougie2, Richard H Aster2,4, Anand Padmanabhan1,2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29259003      PMCID： PMC5805490          DOI： 10.1182/blood-2017-08-803031

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  26 in total

1.  Plasmapheresis in the management of heparin-induced thrombocytopenia.

Authors:  J A Robinson; B E Lewis
Journal:  Semin Hematol       Date:  1999-01       Impact factor: 3.851

2.  Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment.

Authors:  Ariella Tvito; Tamam Bakchoul; Jacob M Rowe; Andreas Greinacher; Chezi Ganzel
Journal:  Am J Hematol       Date:  2015-02-27       Impact factor: 10.047

3.  IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.

Authors:  Anand Padmanabhan; Curtis G Jones; Shannon M Pechauer; Brian R Curtis; Daniel W Bougie; Mehraboon S Irani; Barbara J Bryant; Jack B Alperin; Thomas G Deloughery; Kevin P Mulvey; Binod Dhakal; Renren Wen; Demin Wang; Richard H Aster
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

4.  Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin.

Authors:  Nebojsa M Antonijevic; Nebojsa B Savic; Jovan Perunicic; Mirjana Kovac; Danijela Mikovic; Milica Stanojevic; Branko Calija; Rajko A Milosevic; Slobodan D Obradovic; Zorana Vasiljevic
Journal:  J Clin Apher       Date:  2006-12       Impact factor: 2.821

Review 5.  Transfusion Reactions.

Authors:  William J Savage
Journal:  Hematol Oncol Clin North Am       Date:  2016-06       Impact factor: 3.722

Review 6.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Authors:  Joseph Schwartz; Anand Padmanabhan; Nicole Aqui; Rasheed A Balogun; Laura Connelly-Smith; Meghan Delaney; Nancy M Dunbar; Volker Witt; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2016-06       Impact factor: 2.821

7.  Heparin-associated thrombocytopenia: alternative managements.

Authors:  J S Vender; E B Matthew; I M Silverman; H Konowitz; P C Dau
Journal:  Anesth Analg       Date:  1986-05       Impact factor: 5.108

Review 8.  Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.

Authors:  Theodore E Warkentin; Menaka Pai; Lori-Ann Linkins
Journal:  Blood       Date:  2017-06-23       Impact factor: 22.113

9.  Treating heparin-induced thrombocytopenia. The unconventional way!

Authors:  Hikmat N Abdel-Razeq; Ali A Bajouda; Manar M Khalil; Abdullah K Ashmeg
Journal:  Saudi Med J       Date:  2004-09       Impact factor: 1.484

Review 10.  Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.

Authors:  Steven E McKenzie; Bruce S Sachais
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284
View more
  5 in total

1.  Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.

Authors:  Oluwatoyosi A Onwuemene; Nicole D Zantek; Marian A Rollins-Raval; Jay S Raval; Joseph E Kiss; Tina S Ipe; Maragatha Kuchibhatla; Monica B Pagano; Edward C C Wong
Journal:  J Clin Apher       Date:  2019-05-22       Impact factor: 2.821

2.  Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.

Authors:  Mehraboon Irani; Eric Siegal; Abhay Jella; Richard Aster; Anand Padmanabhan
Journal:  Transfusion       Date:  2018-12-17       Impact factor: 3.157

3.  A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.

Authors:  Maaike Rijkers; Anno Saris; Sebastiaan Heidt; Arend Mulder; Leendert Porcelijn; Frans H J Claas; Ruben Bierings; Frank W G Leebeek; A J Gerard Jansen; Gestur Vidarsson; Jan Voorberg; Masja de Haas
Journal:  Haematologica       Date:  2018-06-01       Impact factor: 9.941

4.  Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.

Authors:  Maaike Rijkers; David Schmidt; Nina Lu; Cynthia S M Kramer; Sebastiaan Heidt; Arend Mulder; Leendert Porcelijn; Frans H J Claas; Frank W G Leebeek; A J Gerard Jansen; Ilse Jongerius; Sacha S Zeerleder; Gestur Vidarsson; Jan Voorberg; Masja de Haas
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

Review 5.  Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).

Authors:  Nadia Gabarin; Donald M Arnold; Ishac Nazy; Theodore E Warkentin
Journal:  Semin Hematol       Date:  2022-03-07       Impact factor: 3.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.